Difficulty: Medium
Average Score: 90%
Practice
A patient is being treated with chemotherapy. The nurse revises the patient's care plan based on which result?
Correct answer
C
Rationale
In the context of a patient undergoing chemotherapy, revising the care plan based on a platelet count of 50,000/┬ÁL is crucial. Chemotherapy often leads to bone marrow suppression, resulting in decreased platelet production and an increased risk of bleeding. Monitoring platelet counts helps in assessing the patient's risk of bleeding and guides interventions such as platelet transfusions or adjustments to the chemotherapy regimen to prevent further bone marrow suppression.
Option A, WBC count of 4000/┬ÁL, is not the most critical parameter to monitor in this scenario. While low WBC counts can increase the risk of infection, platelet count is more directly associated with bleeding complications in the context of chemotherapy.
Option B, RBC count of 3.8 ├ù 106/┬ÁL, primarily reflects the patient's oxygen-carrying capacity and is not the immediate concern when assessing for complications related to chemotherapy.
Option D, Hematocrit (Hct) of 39%, is a measure of the proportion of blood volume occupied by red blood cells and is not as sensitive an indicator of bleeding risk as platelet count.
In an educational context, understanding the significance of monitoring different hematologic parameters in patients undergoing chemotherapy is vital for nurses and healthcare professionals. This knowledge enables them to provide safe and effective care, detect potential complications early, and intervene promptly to optimize patient outcomes.
Option A, WBC count of 4000/┬ÁL, is not the most critical parameter to monitor in this scenario. While low WBC counts can increase the risk of infection, platelet count is more directly associated with bleeding complications in the context of chemotherapy.
Option B, RBC count of 3.8 ├ù 106/┬ÁL, primarily reflects the patient's oxygen-carrying capacity and is not the immediate concern when assessing for complications related to chemotherapy.
Option D, Hematocrit (Hct) of 39%, is a measure of the proportion of blood volume occupied by red blood cells and is not as sensitive an indicator of bleeding risk as platelet count.
In an educational context, understanding the significance of monitoring different hematologic parameters in patients undergoing chemotherapy is vital for nurses and healthcare professionals. This knowledge enables them to provide safe and effective care, detect potential complications early, and intervene promptly to optimize patient outcomes.